Facial contact dermatitis due to spironolactone in an anti-acne cream.
Vincenzi
C
C
Department of Dermatology, University of Bologna, Italy.
Trevisi
P
P
Farina
P
P
Stinchi
C
C
Tosti
A
A
D000152:Acne Vulgaris / Q000188:drug therapy; D000279:Administration, Cutaneous; D000328:Adult; D003877:Dermatitis, Contact / Q000209:etiology*; D003875:Drug Eruptions / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D006801:Humans; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
D013148:Spironolactone